title: [Invasive Candida infection in surgical patients: a valid clinical entity].
abstract: OBJECTIVE
  Establishment of a case definition for invasive candidosis in postsurgical intensive care patients.
  
  
  METHODS
  During the period of 1996-1999, 8 cases of invasive candidosis were observed on a surgical intensive care unit. Patient records were evaluated with respect to diagnostic criteria and response to antimycotic therapy.
  
  
  RESULTS
  Patients included 3 women and 5 men with a mean age of 62.7 (37-85) years. Candida peritonitis (n = 6) occurred after surgery or perforation of the intestinal tract, and Candida pneumonia was due to artificial ventilation (n = 3). C. albicans was isolated in all 8 cases, but mixed infections with other Candida spp. occurred in 3 cases. The Candida serum antigen test yielded a positive result in only 2/8 cases. I.v. therapy with fluconazole was successful in 7 cases, one patient with severe initial disease died with ongoing infection. With the exception of the lethal case, all patients showed a diagnostic serum antibody test, proving systemic candida infection.
  
  
  CONCLUSIONS
  Based on the case descriptions, we propose the following definition of invasive candidosis: (1) Clinical signs of infection after surgery, (2) absence of bacterial pathogens and/or failure to respond to systemic antibiotics, (3) cultivation of Candida spp. from normally sterile sites or abundant growth in tracheal aspirate, (4) response to antimycotic therapy and (5) diagnostic serum antibody test. This definition proved to be valid for our patients and could be used as an inclusion criterion for future clinical studies of serodiagnosis of Candida infection or antimycotic chemotherapy.
authors.affiliation: Sektion Operative Intensivmedizin, Abt. Klin. Anästhesiologie, Universitätsklinikum Ulm.
authors.forename: G
authors.initials: G
authors.lastname: Geldner
authors.forename: M
authors.initials: M
authors.lastname: Ruhnke
authors.forename: P
authors.initials: P
authors.lastname: Lepper
authors.forename: A
authors.initials: A
authors.lastname: Penk
authors.forename: H
authors.initials: H
authors.lastname: Wiedeck
authors.forename: A
authors.initials: A
authors.lastname: Essig
authors.forename: M
authors.initials: M
authors.lastname: Trautmann
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000935:Antifungal Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000453:epidemiology* / Q000473:pathology; D003428:Cross Infection; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology* / Q000473:pathology*
chemical_list: D000935:Antifungal Agents; D015725:Fluconazole
vernacular_title: Die invasive Candidainfektion chirurgischer Patienten: Eine valide klinische Entität.